Corporate Round - Innate Pharma - Oct 24, 2018 Funding Round Profile - Cointime

Bitcoin $98,598.84 +0.55%
Ethereum $3,333.58 +6.27%
BNB $623.13 +2.44%
Optimism $2.10 +25.57%
Arbitrum $0.78 +12.82%
Solana $257.69 +6.67%
Polygon $0.46 +5.38%
Cosmos $6.73 +10.60%
Avalanche $36.80 +9.15%

Bitcoin $98,598.84 +0.55%
Ethereum $3,333.58 +6.27%
BNB $623.13 +2.44%
Optimism $2.10 +25.57%
Arbitrum $0.78 +12.82%
Solana $257.69 +6.67%
Polygon $0.46 +5.38%
Cosmos $6.73 +10.60%
Avalanche $36.80 +9.15%

Innate Pharma

company

Funding Round

Corporate Round

Money Raised

€ 62.60M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
AstraZeneca	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 1, 2004	Series C	€ 15M	Novo Nordisk,Akka Venture,etc.	Detail
Jan 1, 2002	Series B	€ 20M	Akka Venture	Detail